NF-κB signaling pathways regulated by CARMA family of scaffold proteins

Cell Research

Volumn 21, Issue 1, 2011, Pages 55-70

  Blonska, Marzenna ^a   Lin, Xin ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Bcl10; CARD9; CARMA1; CARMA2; CARMA3; IKK; NEMO; NF B

Indexed keywords

BCL10 PROTEIN, HUMAN; CARD10 PROTEIN, HUMAN; CARD11 PROTEIN, HUMAN; CARD14 PROTEIN, HUMAN; CASPASE; CASPASE RECRUITMENT DOMAIN SIGNALING PROTEIN; GUANYLATE CYCLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; MALT1 PROTEIN, HUMAN; MEMBRANE PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR PROTEIN;

CHEMISTRY; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CARD SIGNALING ADAPTOR PROTEINS; CASPASES; GUANYLATE CYCLASE; HUMANS; MEMBRANE PROTEINS; NEOPLASM PROTEINS; NF-KAPPA B; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION;

EID: 78650901943     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2010.182     Document Type: Review

References (162)

1. Shaw AS, Filbert EL. Scaffold proteins and immune-cell signalling. Nat Rev Immunol 2009; 9:47-56.
2. Defea KA. Beta-arrestins as regulators of signal termination and transduction: How do they determine what to scaffold? Cell Signal 2010 Oct 12. doi:10.1016/j.cellsig.2010.10.004
3. Burack WR, Cheng AM, Shaw AS. Scaffolds, adaptors and linkers of TCR signaling: theory and practice. Curr Opin Immunol 2002; 14:312-316.
4. Locasale JW, Shaw AS, Chakraborty AK. Scaffold proteins confer diverse regulatory properties to protein kinase cascades. Proc Natl Acad Sci USA 2007; 104:13307-13312.
5. Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008; 132:344-362.
6. Sun J, Lin X. Beta-arrestin 2 is required for lysophosphatidic acid-induced NF-kappaB activation. Proc Natl Acad Sci USA 2008; 105:17085-17090.
7. Hara H, Ishihara C, Takeuchi A, et al. The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors. Nat Immunol 2007; 8:619-629.
8. Hara H, Ishihara C, Takeuchi A, et al. Cell type-specific regulation of ITAM-mediated NF-kappaB activation by the adaptors, CARMA1 and CARD9. J Immunol 2008; 181:918-930.
9. Sun SC, Ley SC. New insights into NF-kappaB regulation and function. Trends Immunol 2008; 29:469-478.
10. Hacker H, Karin M. Regulation and function of IKK and IKK-related kinases. Sci STKE 2006; 2006:re13.
11. Simeoni L, Kliche S, Lindquist J, Schraven B. Adaptors and linkers in T and B cells. Curr Opin Immunol 2004; 16:304-313.
12. Blonska M, Lin X. CARMA1-mediated NF-kappaB and JNK activation in lymphocytes. Immunol Rev 2009; 228:199-211.
13. Hara H, Saito T. CARD9 versus CARMA1 in innate and adaptive immunity. Trends Immunol 2009; 30:234-242.
14. Bertin J, Wang L, Guo Y, et al. CARD11 and CARD14 are novel caspase recruitment domain (CARD)/membraneassociated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-kappa B. J Biol Chem 2001; 276:11877-11882.
15. Gaide O, Martinon F, Micheau O, et al. Carma1, a CARDcontaining binding partner of Bcl10, induces Bcl10 phosphorylation and NF-kappaB activation. FEBS Lett 2001; 496:121-127.
16. Wang L, Guo Y, Huang WJ, et al. Card10 is a novel caspase recruitment domain/membrane-associated guanylate kinase family member that interacts with BCL10 and activates NFkappa B. J Biol Chem 2001; 276:21405-21409.
17. McAllister-Lucas LM, Inohara N, Lucas PC, et al. Bimp1, a MAGUK family member linking protein kinase C activation to Bcl10-mediated NF-kappaB induction. J Biol Chem 2001; 276:30589-30597.
18. Roth RB, Hevezi P, Lee J, et al. Gene expression analyses reveal molecular relationships among 20 regions of the human CNS. Neurogenetics 2006; 7:67-80.
19. Matsumoto R, Wang D, Blonska M et al. Phosphorylation of CARMA1 plays a critical role in T Cell receptor-mediated NF-kappaB activation. Immunity 2005; 23:575-585.
20. Lin X, Wang D. The roles of CARMA1, Bcl10, and MALT1 in antigen receptor signaling. Semin Immunol 2004; 16:429-435.
21. Wegener E, Oeckinghaus A, Papadopoulou N, et al. Essential role for IkappaB kinase beta in remodeling Carma1-Bcl10- Malt1 complexes upon T cell activation. Mol Cell 2006; 23:13-23.
22. We g e n e r E , K r a p p m a n n D . C A R D - B c l 1 0 - M a l t 1 signalosomes: missing link to NF-kappaB. Sci STKE 2007; 2007:pe21.
23. Wang D, You Y, Case SM, et al. A requirement for CARMA1 in TCR-induced NF-kappa B activation. Nat Immunol 2002; 3:830-835.
24. Gaide O, Favier B, Legler DF, et al. CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-kappa B activation. Nat Immunol 2002; 3:836-843.
25. Pomerantz JL, Denny EM, Baltimore D. CARD11 mediates factor-specific activation of NF-kappaB by the T cell receptor complex. EMBO J 2002; 21:5184-5194.
26. Hara H, Wada T, Bakal C, et al. The MAGUK family protein CARD11 is essential for lymphocyte activation. Immunity 2003; 18:763-775.
27. Egawa T, Albrecht B, Favier B, et al. Requirement for CARMA1 in antigen receptor-induced NF-kappa B activation and lymphocyte proliferation. Curr Biol 2003; 13:1252-1258.
28. Newton K, Dixit V. Mice lacking the CARD of CARMA1 exhibit defective B lymphocyte development and impaired proliferation of their B and T lymphocytes. Curr Biol 2003; 13:1247-1251.
29. Ruland J, Duncan GS, Elia A, et al. Bcl10 is a positive regulator of antigen receptor-induced activation of NFkappaB and neural tube closure. Cell 2001; 104:33-42.
30. Willis TG, Jadayel DM, Du MQ, et al. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 1999; 96:35-45.
31. Zhang Q, Siebert R, Yan M, et al. Inactivating mutations and overexpression of BCL10, a caspase recruitment domaincontaining gene, in MALT lymphoma with t(1;14)(p22;q32). Nat Genet 1999; 22:63-68.
32. Yan M, Lee J, Schilbach S, Goddard A, Dixit V. mE10, a novel caspase recruitment domain-containing proapoptotic molecule. J Biol Chem 1999; 274:10287-10292.
33. T h o m e M , M a r t i n o n F, H o f m a n n K et al. E q u i n e herpesvirus-2 E10 gene product, but not its cellular homologue, activates NF-kappaB transcription factor and c-Jun N-terminal kinase. J Biol Chem 1999; 274:9962-9968.
34. Koseki T, Inohara N, Chen S et al. CIPER, a novel NF kappaB-activating protein containing a caspase recruitment domain with homology to Herpesvirus-2 protein E10. J Biol Chem 1999; 274:9955-9961.
35. Xue L, Morris SW, Orihuela C, et al. Defective development and function of Bcl10-deficient follicular, marginal zone and B1 B cells. Nat Immunol 2003; 4:857-865.
36. Schaefer BC, Kappler JW, Kupfer A, Marrack P. Complex and dynamic redistribution of NF-kappaB signaling intermediates in response to T cell receptor stimulation. Proc Natl Acad Sci USA 2004; 101:1004-1009.
37. Rossman JS, Stoicheva NG, Langel FD et al. POLKADOTS are foci of functional interactions in T-Cell receptor-mediated signaling to NF-kappaB. Mol Biol Cell 2006; 17:2166-2176.
38. Blonska M, Pappu BP, Matsumoto R, et al. The CARMA1- Bcl10 signaling complex selectively regulates JNK2 kinase in the T cell receptor-signaling pathway. Immunity 2007; 26:55-66.
39. Rueda D, Gaide O, Ho L, et al. Bcl10 controls TCR- and FcgammaR-induced actin polymerization. J Immunol 2007; 178:4373-4384.
40. Thome M, Charton JE, Pelzer C, Hailfinger S. Antigen receptor signaling to NF-kappaB via CARMA1, BCL10, and MALT1. Cold Spring Harb Perspect Biol 2010; 2:a003004.
41. Akagi T, Motegi M, Tamura A, et al. A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Oncogene 1999; 18:5785-5794.
42. Uren AG, O'Rourke K, Aravind LA, et al. Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol Cell 2000; 6:961-967.
43. Ye H, Gong L, Liu H, et al. MALT lymphoma with t(14;18)(q32;q21)/IGH- MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression. J Pathol 2005; 205:293-301.
44. Du MQ. MALT lymphoma : recent advances in aetiology and molecular genetics. J Clin Exp Hematop 2007; 47:31-42.
45. Lucas PC, Yonezumi M, Inohara N, et al. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway. J Biol Chem 2001; 276:19012-19019.
46. Baens M, Fevery S, Sagaert X, et al. Selective expansion of marginal zone B cells in Emicro-API2-MALT1 mice is linked to enhanced IkappaB kinase gamma polyubiquitination. Cancer Res 2006; 66:5270-5277.
47. Ruefli-Brasse AA, French DM, Dixit VM. Regulation of NFkappaB- dependent lymphocyte activation and development by paracaspase. Science 2003; 302:1581-1584.
48. Ruland J, Duncan GS, Wakeham A, Mak TW. Differential requirement for Malt1 in T and B cell antigen receptor signaling. Immunity 2003; 19:749-758.
49. Ferch U, zum Buschenfelde CM, Gewies A, et al. MALT1 di rects B cell receptor-induced canonical nuclear factor-kappaB signaling selectively to the c-Rel subunit. Nat Immunol 2007; 8:984-991.
50. Zhou H, Wertz I, O'Rourke K, et al. Bcl10 activates the NFkappaB pathway through ubiquitination of NEMO. Nature 2004; 427:167-171.
51. Kawadler H, Gantz MA, Riley JL, Yang X. The paracaspase MALT1 controls caspase-8 activation during lymphocyte proliferation. Mol Cell 2008; 31:415-421.
52. Rebeaud F, Hailfinger S, Posevitz-Fejfar A, et al. The proteolytic activity of the paracaspase MALT1 is key in T cell activation. Nat Immunol 2008; 9:272-281.
53. Su H, Bidere N, Zheng L, et al. Requirement for caspase-8 in NF-kappaB activation by antigen receptor. Science 2005; 307:1465-1468.
54. Bidere N, Snow AL, Sakai K, Zheng L, Lenardo MJ. Caspase-8 regulation by direct interaction with TRAF6 in T cell receptor-induced NF-kappaB activation. Curr Biol 2006; 16:1666-1671.
55. Misra RS, Russell JQ, Koenig A, et al. Caspase-8 and c-FLIPL associate in lipid rafts with NF-kappaB adaptors during T cell activation. J Biol Chem 2007; 282:19365-19374.
56. Malarkannan S, Regunathan J, Chu H, et al. Bcl10 plays a divergent role in NK cell-mediated cytotoxicity and cytokine generation. J Immunol 2007; 179:3752-3762.
57. Gross O, Grupp C, Steinberg C, et al. Multiple ITAM-coupled NK-cell receptors engage the Bcl10/Malt1 complex via Carma1 for NF-kappaB and MAPK activation to selectively control cytokine production. Blood 2008; 112:2421-2428.
58. Klemm S, Gutermuth J, Hultner L, et al. The Bcl10-Malt1 complex segregates Fc epsilon RI-mediated nuclear factor kappa B activation and cytokine production from mast cell degranulation. J Exp Med 2006; 203:337-347.
59. Chen Y, Pappu BP, Zeng H, et al. B cell lymphoma 10 is essential for FcepsilonR-mediated degranulation and IL-6 production in mast cells. J Immunol 2007; 178:49-57.
60. Hara H, Bakal C, Wada T, et al. The molecular adapter Carma1 controls entry of IkappaB kinase into the central immune synapse. J Exp Med 2004; 200:1167-1177.
61. Wa n g D, Ma t s umo t o R, Yo u Y, e t a l . CD3 /CD2 8 costimulation-induced NF-kappaB activation is mediated by recruitment of protein kinase C-theta, Bcl10, and IkappaB kinase beta to the immunological synapse through CARMA1. Mol Cell Biol 2004; 24:164-171.
62. Dimitratos SD, Woods DF, Stathakis DG, Bryant PJ. Signaling pathways are focused at specialized regions of the plasma membrane by scaffolding proteins of the MAGUK family. Bioessays 1999; 21:912-921.
63. Medeiros RB, Burbach BJ, Mueller KL, et al. Regulation of NF-kappaB activation in T cells via association of the adapter proteins ADAP and CARMA1. Science 2007; 316:754-758.
64. Sommer K, Guo B, Pomerantz JL, et al. Phosphorylation of the CARMA1 linker controls NF-kappaB activation. Immunity 2005; 23:561-574.
65. Shinohara H, Maeda S, Watarai H, Kurosaki T. IkappaB kinase beta-induced phosphorylation of CARMA1 contributes to CARMA1 Bcl10 MALT1 complex formation in B cells. J Exp Med 2007; 204:3285-3293.
66. McCully RR, Pomerantz JL. The protein kinase C-responsive inhibitory domain of CARD11 functions in NF-kappaB activation to regulate the association of multiple signaling cofactors that differentially depend on Bcl10 and MALT1 for association. Mol Cell Biol 2008; 28:5668-5686.
67. Lee KY, D'Acquisto F, Hayden MS, Shim JH, Ghosh S. PDK1 nucleates T cell receptor-induced signaling complex for NF-kappaB activation. Science 2005; 308:114-118.
68. Shinohara H, Yasuda T, Aiba Y, et al. PKC beta regulates BCR-mediated IKK activation by facilitating the interaction between TAK1 and CARMA1. J Exp Med 2005; 202:1423-1431.
69. Narayan P, Holt B, Tosti R, Kane LP. CARMA1 is required for Akt-mediated NF-kappaB activation in T cells. Mol Cell Biol 2006; 26:2327-2336.
70. Bidere N, Ngo VN, Lee J, et al. Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival. Nature 2009; 458:92-96.
71. Brenner D, Brechmann M, Rohling S, et al. Phosphorylation of CARMA1 by HPK1 is critical for NF-kappaB activation in T cells. Proc Natl Acad Sci USA 2009; 106:14508-14513.
72. Ishiguro K, Green T, Rapley J, et al. Ca2+/calmodulindependent protein kinase II is a modulator of CARMA1- mediated NF-kappaB activation. Mol Cell Biol 2006; 26:5497-5508.
73. Qiao G, Li Z, Molinero L, et al. T-cell receptor-induced NFkappaB activation is negatively regulated by E3 ubiquitin ligase Cbl-b. Mol Cell Biol 2008; 28:2470-2480.
74. Che T, You Y, Wang D, et al. MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-kappaB activation. J Biol Chem 2004; 279:15870-15876.
75. Sun L, Deng L, Ea CK, Xia ZP, Chen ZJ. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol Cell 2004; 14:289-301.
76. Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 1997; 91:243-252.
77. Rothwarf DM, Zandi E, Natoli G, Karin M. IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. Nature 1998; 395:297-300.
78. Li ZW, Chu W, Hu Y, et al. The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J Exp Med 1999; 189:1839-1845.
79. S h amb h a r k a r PB, Bl o n s k a M, P a p p u BP, e t a l . Phosphorylation and ubiquitination of the IkappaB kinase complex by two distinct signaling pathways. EMBO J 2007; 26:1794-1805.
80. Tusche MW, Ward LA, Vu F, et al. Differential requirement of MALT1 for BAFF-induced outcomes in B cell subsets. J Exp Med 2009; 206:2671-2683.
81. Delhase M, Hayakawa M, Chen Y, Karin M. Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science 1999; 284:309-313.
82. Ling L, Cao Z, Goeddel DV. NF-kappaB-inducing kinase ac tivates IKK-alpha by phosphorylation of Ser-176. Proc Natl Acad Sci USA 1998; 95:3792-3797.
83. Sato S, Sanjo H, Tsujimura T, et al. TAK1 is indispensable for development of T cells and prevention of colitis by the generation of regulatory T cells. Int Immunol 2006; 18:1405-1411.
84. Shim JH, Xiao C, Paschal AE, et al. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev 2005; 19:2668-2681.
85. Wan YY, Chi H, Xie M, Schneider MD, Flavell RA. The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function. Nat Immunol 2006; 7:851-858.
86. Liu HH, Xie M, Schneider MD, Chen ZJ. Essential role of TAK1 in thymocyte development and activation. Proc Natl Acad Sci USA 2006; 103:11677-11682.
87. Sun W, Li H, Yu Y, et al. MEKK3 is required for lysophosphatidic acid-induced NF-kappaB activation. Cell Signal 2009; 21:1488-1494.
88. Shinohara H, Yamasaki S, Maeda S, Saito T, Kurosaki T. Regulation of NF-kappaB-dependent T cell activation and development by MEKK3. Int Immunol 2009; 21:393-401.
89. Yang J, Lin Y, Guo Z, et al. The essential role of MEKK3 in TNF-induced NF-kappaB activation. Nat Immunol 2001; 2:620-624.
90. Huang Q, Yang J, Lin Y, et al. Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3. Nat Immunol 2004; 5:98-103.
91. Abbasi S, Su B, Kellems RE, Yang J, Xia Y. The essential role of MEKK3 signaling in angiotensin II-induced calcineurin/ nuclear factor of activated T-cells activation. J Biol Chem 2005; 280:36737-36746.
92. Stilo R, Liguoro D, Di Jeso B, et al. Physical and functional interaction of CARMA1 and CARMA3 with Ikappa kinase gamma-NFkappaB essential modulator. J Biol Chem 2004; 279:34323-34331.
93. Ea CK, Deng L, Xia ZP, Pineda G, Chen ZJ. Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell 2006; 22:245-257.
94. Wu CJ, Conze DB, Li T, Srinivasula SM, Ashwell JD. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation. Nat Cell Biol 2006; 8:398-406.
95. Wu CJ, Ashwell JD. NEMO recognition of ubiquitinated Bcl10 is required for T cell receptor-mediated NF-kappaB activation. Proc Natl Acad Sci USA 2008; 105:3023-3028.
96. Tang ED, Wang CY, Xiong Y, Guan KL. A role for NFkappaB essential modifier/IkappaB kinase-gamma (NEMO/ IKKgamma) ubiquitination in the activation of the IkappaB kinase complex by tumor necrosis factor-alpha. J Biol Chem 2003; 278:37297-37305.
97. Israel A. The IKK complex, a central regulator of NF-kappaB activation. Cold Spring Harb Perspect Biol 2010; 2:a000158.
98. Li H, Kobayashi M, Blonska M, You Y, Lin X. Ubiquitination of RIP is required for tumor necrosis factor alpha-induced NF-kappaB activation. J Biol Chem 2006; 281:13636-13643.
99. Conze DB, Wu CJ, Thomas JA, Landstrom A, Ashwell JD. Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and toll-like receptor-mediated NFkappaB activation. Mol Cell Biol 2008; 28:3538-3547.
100. Oeckinghaus A, Wegener E, Welteke V, et al. Malt1 ubiquitination triggers NF-kappaB signaling upon T-cell activation. EMBO J 2007; 26:4634-4645.
101. Ni CY, Wu ZH, Florence WC, et al. Cutting edge: K63-linked polyubiquitination of NEMO modulates TLR signaling and inflammation in vivo. J Immunol 2008; 180:7107-7111.
102. King CG, Kobayashi T, Cejas PJ, et al. TRAF6 is a T cellintrinsic negative regulator required for the maintenance of immune homeostasis. Nat Med 2006; 12:1088-1092.
103. Moreno-Garcia ME, Sommer K, Haftmann C, et al. Serine 649 phosphorylation within the protein kinase C-regulated domain down-regulates CARMA1 activity in lymphocytes. J Immunol 2009; 183:7362-7370.
104. Kojo S, Elly C, Harada Y, et al. Mechanisms of NKT cell anergy induction involve Cbl-b-promoted monoubiquitination of CARMA1. Proc Natl Acad Sci USA 2009; 106:17847-17851.
105. Moreno-Garcia ME, Sommer K, Shinohara H, et al. MAGUK-controlled ubiquitination of CARMA1 modulates lymphocyte NF-kappaB activity. Mol Cell Biol 2010; 30:922-934.
106. Welteke V, Eitelhuber A, Duwel M, et al. COP9 signalosome controls the Carma1-Bcl10-Malt1 complex upon T-cell stimulation. EMBO Rep 2009; 10:642-648.
107. I s h i g u r o K , A n d o T, G o t o H , X a v i e r R . B c l 1 0 i s phosphorylated on Ser138 by Ca2+/calmodulin-dependent protein kinase II. Mol Immunol 2007; 44:2095-2100.
108. Zeng H, Di L, Fu G, et al. Phosphorylation of Bcl10 negatively regulates T-cell receptor-mediated NF-kappaB activation. Mol Cell Biol 2007; 27:5235-5245.
109. Lobry C, Lopez T, Israel A, Weil R. Negative feedback loop in T cell activation through IkappaB kinase-induced phosphorylation and degradation of Bcl10. Proc Natl Acad Sci USA 2007; 104:908-913.
110. Ngo VN, Davis RE, Lamy L, et al. A loss-of-function RNA interference screen for molecular targets in cancer. Nature 2006; 441:106-110.
111. Li Z, Wang H, Xue L, et al. Emu-BCL10 mice exhibit constitutive activation of both canonical and noncanonical NF-kappaB pathways generating marginal zone (MZ) B-cell expansion as a precursor to splenic MZ lymphoma. Blood 2009; 114:4158-4168.
112. Oshiro A, Tagawa H, Ohshima K, et al. Identification of subtype-specific genomic alterations in aggressive adult T-cell leukemia/lymphoma. Blood 2006; 107:4500-4507.
113. Nakamura S, Matsumoto T, Yada S, et al. Overexpression of caspase recruitment domain (CARD) membrane-associated guanylate kinase 1 (CARMA1) and CARD9 in primary gastric B-cell lymphoma. Cancer 2005; 104:1885-1893.
114. Tanner MJ, Hanel W, Gaffen SL, Lin X. CARMA1 coiledcoil domain is involved in the oligomerization and subcellular localization of CARMA1 and is required for T cell receptorinduced NF-kappaB activation. J Biol Chem 2007; 282:17141-17147.
115. Lenz G, Davis RE, Ngo VN, et al. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science 2008; 319:1676-1679.
116. Compagno M, Lim WK, Grunn A, et al. Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. Nature 2009; 459:717-721.
117. Montesinos-Rongen M, Schmitz R, Brunn A, et al. Mutations of CARD11 but not TNFAIP3 may activate the NF-kappaB pathway in primary CNS lymphoma. Acta Neuropathol 2010; 120:529-535.
118. Lamason RL, McCully RR, Lew SM, Pomerantz JL. Oncogenic CARD11 Mutations Induce Hyperactive Signaling by Disrupting Autoinhibition by the PKC-Responsive Inhibitory Domain. Biochemistry 2010; 49:8240-8250.
119. Hailfinger S, Lenz G, Ngo V, et al. Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma. Proc Natl Acad Sci USA 2009; 106:19946-19951.
120. Ferch U, Kloo B, Gewies A, et al. Inhibition of MALT1 protease activity is selectively toxic for activated B celllike diffuse large B cell lymphoma cells. J Exp Med 2009; 206:2313-2320.
121. Davis RE, Brown KD, Siebenlist U, Staudt LM. Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med 2001; 194:1861-1874.
122. Lam LT, Davis RE, Pierce J, et al. Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling. Clin Cancer Res 2005; 11:28-40.
123. Grabiner BC, Blonska M, Lin PC, et al. CARMA3 deficiency abrogates G protein-coupled receptor-induced NF-{kappa}B activation. Genes Dev 2007; 21:984-996.
124. Lefkowitz RJ. Historical review: a brief history and personal retrospective of seven-transmembrane receptors. Trends Pharmacol Sci 2004; 25:413-422.
125. Mills GB, Moolenaar WH. The emerging role of lysophosphatidic acid in cancer. Nat Rev Cancer 2003; 3:582-591.
126. Zhao Y, Tong J, He D, et al. Role of lysophosphatidic acid receptor LPA2 in the development of allergic airway inflammation in a murine model of asthma. Respir Res 2009; 10:114.
127. Ye RD. Regulation of nuclear factor kappaB activation by G-protein-coupled receptors. J Leukoc Biol 2001; 70:839-848.
128. McAllister-Lucas LM, Ruland J, Siu K, et al. CARMA3/ Bcl10/MALT1- dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells. Proc Natl Acad Sci USA 2007; 104:139-144.
129. McAllister-Lucas LM, Jin X, Gu S, et al. The CARMA3- Bcl10-MALT1 signalosome promotes angiotensin IIdependent vascular inflammation and atherogenesis. J Biol Chem 2010; 285:25880-25884.
130. Medoff BD, Landry AL, Wittbold KA, et al. CARMA3 mediates lysophosphatidic acid-stimulated cytokine secretion by bronchial epithelial cells. Am J Respir Cell Mol Biol 2009; 40:286-294.
131. Zhao Y, Natarajan V. Lysophosphatidic acid signaling in airway epithelium: role in airway inflammation and remodeling. Cell Signal 2009; 21:367-377.
132. Georas SN, Berdyshev E, Hubbard W, et al. Lysophosphatidic acid is detectable in human bronchoalveolar lavage fluids at baseline and increased after segmental allergen challenge. Clin Exp Allergy 2007; 37:311-322.
133. Mahanivong C, Chen HM, Yee SW, et al. Protein kinase C alpha-CARMA3 signaling axis links Ras to NF-kappa B for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells. Oncogene 2008; 27:1273-1280.
134. Klemm S, Zimmermann S, Peschel C, Mak TW, Ruland J. Bcl10 and Malt1 control lysophosphatidic acid-induced NFkappaB activation and cytokine production. Proc Natl Acad Sci USA 2007; 104:134-138.
135. Wang D, You Y, Lin PC, et al. Bcl10 plays a critical role in NF-kappaB activation induced by G protein-coupled receptors. Proc Natl Acad Sci USA 2007; 104:145-150.
136. Cummings R, Zhao Y, Jacoby D, et al. Protein kinase Cdelta mediates lysophosphatidic acid-induced NF-kappaB activation and interleukin-8 secretion in human bronchial epithelial cells. J Biol Chem 2004; 279:41085-41094.
137. Lefkowitz RJ, Shenoy SK. Transduction of receptor signals by beta-arrestins. Science 2005; 308:512-517.
138. Sun L, Carpenter G. Epidermal growth factor activation of NF-kappaB is mediated through IkappaBalpha degradation and intracellular free calcium. Oncogene 1998; 16:2095-2102.
139. Biswas DK, Cruz AP, Gansberger E, Pardee AB. Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells. Proc Natl Acad Sci USA 2000; 97:8542-8547.
140. Biswas DK, Iglehart JD. Linkage between EGFR family receptors and nuclear factor kappaB (NF-kappaB) signaling in breast cancer. J Cell Physiol 2006; 209:645-652.
141. Kim HJ, Litzenburger BC, Cui X, et al. Constitutively active type I insulin-like growth factor receptor causes transformation and xenograft growth of immortalized mammary epithelial cells and is accompanied by an epithelial-to-mesenchymal transition mediated by NF-kappaB and snail. Mol Cell Biol 2007; 27:3165-3175.
142. Pons S, Torres-Aleman I. Insulin-like growth factor-I stimulates dephosphorylation of ikappa B through the serine phosphatase calcineurin (protein phosphatase 2B). J Biol Chem 2000; 275:38620-38625.
143. Kaliman P, Canicio J, Testar X, Palacin M, Zorzano A. Insulin-like growth factor-II, phosphatidylinositol 3-kinase, nuclear factor-kappaB and inducible nitric-oxide synthase define a common myogenic signaling pathway. J Biol Chem 1999; 274:17437-17444.
144. Olashaw NE, Kowalik TF, Huang ES, Pledger WJ. Induction of NF-kappa B-like activity by platelet-derived growth factor in mouse fibroblasts. Mol Biol Cell 1992; 3:1131-1139.
145. Romashkova JA, Makarov SS. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 1999; 401:86-90.
146. Byrd VM, Ballard DW, Miller GG, Thomas JW. Fibroblast growth factor-1 (FGF-1) enhances IL-2 production and nuclear translocation of NF-kappaB in FGF receptor-bearing Jurkat T cells. J Immunol 1999; 162:5853-5859.
147. Bushdid PB, Chen CL, Brantley DM, et al. NF-kappaB mediates FGF signal regulation of msx-1 expression. Dev Biol 2001; 237:107-115.
148. Bertin J, Guo Y, Wang L, et al. CARD9 is a novel caspase recruitment domain-containing protein that interacts with BCL10/CLAP and activates NF-kappa B. J Biol Chem 2000; 275:41082-41086.
149. Gross O, Gewies A, Finger K, et al. Card9 controls a non- TLR signalling pathway for innate anti-fungal immunity. Nature 2006; 442:651-656.
150. Hsu YM, Zhang Y, You Y, et al. The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens. Nat Immunol 2007; 8:198-205.
151. Bi L, Gojestani S, Wu W, et al. CARD9 mediates dectin- 2-induced IkappaBalpha kinase ubiquitination leading to activation of NF-kappaB in response to stimulation by the hyphal form of Candida albicans. J Biol Chem 2010; 285:25969-25977.
152. Robinson MJ, Osorio F, Rosas M, et al. Dectin-2 is a Sykcoupled pattern recognition receptor crucial for Th17 responses to fungal infection. J Exp Med 2009; 206:2037-2051.
153. Yamasaki S, Ishikawa E, Sakuma M, et al. Mincle is an ITAM-coupled activating receptor that senses damaged cells. Nat Immunol 2008; 9:1179-1188.
154. Willment JA, Brown GD. C-type lectin receptors in antifungal immunity. Trends Microbiol 2008; 16:27-32.
155. Graham LM, Brown GD. The Dectin-2 family of C-type lectins in immunity and homeostasis. Cytokine 2009; 48:148-155.
156. LeibundGut-Landmann S, Gross O, Robinson MJ, et al. Sykand CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol 2007; 8:630-638.
157. Goodridge HS, Shimada T, Wolf AJ, et al. Differential use of CARD9 by dectin-1 in macrophages and dendritic cells. J Immunol 2009; 182:1146-1154.
158. Saijo S, Ikeda S, Yamabe K, et al. Dectin-2 recognition of alpha-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans. Immunity 2010; 32:681-691.
159. Wu W, Hsu YM, Bi L, Songyang Z, Lin X. CARD9 facilitates microbe-elicited production of reactive oxygen species by regulating the LyGDI-Rac1 complex. Nat Immunol 2009; 10:1208-1214.
160. Werninghaus K, Babiak A, Gross O, et al. Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRgamma-Syk-Card9- dependent innate immune activation. J Exp Med 2009; 206:89-97.
161. Poeck H, Bscheider M, Gross O, et al. Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production. Nat Immunol 2010; 11:63-69.
162. Yang H, Minamishima YA, Yan Q, et al. pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NFkappaB agonist Card9 by CK2. Mol Cell 2007; 28:15-27.